SMAD3 and ovarian carcinoma: To exclude ovarian cancer cell lines with malfunctioned TGF-β signalling, we tested the TGF-β/Smad signalling component, Smad3 and the p21WAF1/CIP1 gene induction under TGF-β treatment for the selected cell lines.